| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |